Table 2 Morphometric parameters of NMJs in untreated, IgG- and CCL2 neutralising antibody-treated GC muscles
From: The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis
Morphometric parameters | ALS untreated | ALS IgG-treated | ALS CCL2 neutr. | |
---|---|---|---|---|
Presynaptic parameters | Axon diameter (µm) | 1.05 ± 0.09 | 1.39 ± 0.08 (p = 0.0002) | 1.37 ± 0.14 (p = 0.0003) |
Nerve terminal area (µm2) | 93.07 ± 13.15 | 130.10 ± 16.32 (p = 0.0010) | 131.99 ± 11.76 (p = 0.0007) | |
Nerve terminal perimeter (µm) | 169.25 ± 22.94 | 235.22 ± 24.08 (p = 0.0004) | 225.51 ± 15.65 (p = 0.0014) | |
Nerve terminal complexity (a.u.) | 4.63 ± 0.17 | 5.11 ± 0.30 (p = 0.0022) | 4.95 ± 0.07 (p = 0.0238) | |
Postsynaptic parameters | AChR area (µm2) | 351.31 ± 43.06 | 375.75 ± 31.99 | 349.90 ± 26.27 |
AChR perimeter (µm) | 128.54 ± 14.80 | 137.80 ± 25.70 | 125.48 ± 8.82 | |
Endplate area (µm2) | 415.26 ± 47.01 | 440.30 ± 38.71 | 415.30 ± 31.45 | |
Endplate perimeter (µm) | 85.28 ± 5.37 | 87.42 ± 4.86 | 84.37 ± 3.42 | |
Endplate diameter (µm) | 33.02 ± 2.82 | 32.71 ± 1.78 | 32.17 ± 2.98 | |
Compactness (a.u.) | 84.51 ± 1.37 | 85.34 ± 1.78 | 84.37 ± 1.32 | |
Fragmentation (a.u.) | 0.12 ± 0.06 | 0.12 ± 0.10 | 0.11 ± 0.05 | |
Others | Area of synaptic contact (µm2) | 88.45 ± 12.45 | 125.43 ± 15.33 (p = 0.0005) | 127.77 ± 9.34 (p = 0.0003) |
Overlap (%) | 25.45 ± 3.38 | 34.54 ± 4.27 (p = 0.0014) | 37.03 ± 2.92 (p = 0.0002) |